Viamet Pharmaceuticals Receives $3,000,100 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=988e0440-1ea8-46c4-b207-0a647f386e8c - Date
12/31/2012 - Company Name
Viamet Pharmaceuticals - Mailing Address
4505 Emperor Blvd. Durham, NC 27703 USA - Company Description
Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology. - Website
http://www.viamet.com - Transaction Type
Venture Equity - Transaction Amount
$3,000,100 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
- Venture Investor
